NDC 70518-0786-2 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0786
- Requested NDC
- 70518-0786-2
- Package NDCs from labels
- 70518-0786-0, 70518-0786-2, 70518-0786-1
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-13 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Proficient Rx LP | 84dba61d-cae2-4f21-9a9e-3088f356f838 | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | c4fe84e3-c291-4220-95c1-a2bd02b1e134 | 2023-02-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 34703033-14c4-459c-8b8f-2f2e1145aff7 | 2023-01-30 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 9492a1cd-c012-4b43-931d-235220065e1e | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 3b80f726-9e1e-4d44-ad4f-afd10e26292f | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 5b476740-e3f0-4f68-b07c-cd9eb2fa27ca | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 8c65d555-8db8-40d9-be30-309ef09f19be | 2023-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 538ea34a-1ac3-48c8-b841-43be09285e12 | 2023-01-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | XLCare Pharmaceuticals, Inc. | 20421665-0401-4f6e-9e1d-232c654efb0f | 2023-01-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Josie Maran Argan Daily Moisturizer SPF47 | ZINC OXIDE, TITANIUM DIOXIDE | Autumn Harp, Inc. | 027821e6-db7d-4c03-956a-00313488ebc7 | 2023-01-14 | Boxed warning, Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 15e6f934-fe66-4640-bdf1-13b389cd9e54 | 2023-01-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 189ad040-07e9-42a5-854c-67633367da74 | 2023-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Amiloride Hydrochloride and Hydrochlorothiazide | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | 8b2c581a-f955-4a8e-bf85-e768e903fd10 | 2022-12-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | 35ed3030-a9b3-4e4e-99cd-6d5c31ad22fa | 2022-11-07 | 0J48LPH2TH | |
| valsartan and hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | bd199010-1d85-4011-939c-4704ecfaba1f | 2022-11-05 | 0J48LPH2TH | |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 35099fd1-1bc9-428b-9b9c-71f574cc4156 | 2022-11-03 | Boxed warning, Warnings, Adverse reactions | 979471 3ST302B24A 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 771afba6-8769-4ea8-afec-358dba0aaefe | 2022-11-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | 8015c22c-d944-4a49-8721-70d0c1b98526 | 2022-10-18 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 5b1f6677-9473-467f-9fb6-efadbd8828e8 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | a9098fc6-3d2a-404f-a4cd-2e181ebbd626 | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.